Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - GW PHARMACEUTICALS PLC | gwph-ex321_6.htm |
| EX-31.2 - EX-31.2 - GW PHARMACEUTICALS PLC | gwph-ex312_11.htm |
| EX-31.1 - EX-31.1 - GW PHARMACEUTICALS PLC | gwph-ex311_7.htm |
| EX-23.2 - EX-23.2 - GW PHARMACEUTICALS PLC | gwph-ex232_9.htm |
| EX-21.1 - EX-21.1 - GW PHARMACEUTICALS PLC | gwph-ex211_8.htm |
| EX-4.4 - EX-4.4 - GW PHARMACEUTICALS PLC | gwph-ex44_147.htm |
| 10-K - 10-K - GW PHARMACEUTICALS PLC | gwph-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-229308 on Form S-3 and Registration Statement Nos. 33-217328 and 333-204389 on Form S-8 of our report dated November 28, 2018, relating to the financial statements of GW Pharmaceuticals plc appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ DELOITTE LLP
London, United Kingdom
February 27, 2020